[FATE] YoY Quarter Result on 30-Jun-2016 [#Q2]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
08-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- -0.37%
YoY- -8.09%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Revenue 2,817 1,027 1,026 1,027 329 0 290 46.04%
PBT -23,478 -19,654 -9,645 -8,408 -7,779 -6,067 -5,534 27.22%
Tax 1,015 376 137 31 2 1 88 50.28%
NP -23,478 -19,654 -9,645 -8,408 -7,779 -6,067 -5,534 27.22%
Tax Rate - - - - - - - -
Total Cost 26,295 20,681 10,671 9,435 8,108 6,067 5,824 28.54%
Ratio Analysis
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
NP Margin -833.44 -1,913.73 -940.06 -818.70 -2,364.44 0.00 -1,908.28 -12.89%
Per Share
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
EPS -0.36 -0.37 -0.23 -0.29 -0.33 -0.30 -0.29 3.66%
EPS Diluted -0.36 -0.37 -0.23 -0.29 -0.33 -0.30 -0.29 3.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.